You just read:

Merz Aesthetics Announces FDA Approval Of XEOMIN® (incobotulinumtoxinA) For The Temporary Improvement In The Appearance Of Moderate To Severe Glabellar Lines In Adult Patients

News provided by

Merz Aesthetics

Jul 21, 2011, 08:11 ET